Cargando…
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
SIMPLE SUMMARY: Apart from genetic changes, cancer is characterized by epigenetic alterations, which indicate modifications in the DNA (such as DNA methylation) and histones (such as methylation and acetylation), as well as gene expression regulation by non-coding (nc)RNAs. These changes can be used...
Autores principales: | Palanca-Ballester, Cora, Rodriguez-Casanova, Aitor, Torres, Susana, Calabuig-Fariñas, Silvia, Exposito, Francisco, Serrano, Diego, Redin, Esther, Valencia, Karmele, Jantus-Lewintre, Eloisa, Diaz-Lagares, Angel, Montuenga, Luis, Sandoval, Juan, Calvo, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233712/ https://www.ncbi.nlm.nih.gov/pubmed/34208598 http://dx.doi.org/10.3390/cancers13123016 |
Ejemplares similares
-
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014) -
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
por: Villalba, Maria, et al.
Publicado: (2019) -
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
por: Otegui, Nerea, et al.
Publicado: (2023) -
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019) -
Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision Oncology
por: Valencia, Karmele, et al.
Publicado: (2021)